{"result": "(\"entity\"<|>RUMINATION SYNDROME<|>EVENT<|>Rumination syndrome is a poorly understood disorder that is likely underdiagnosed, characterized by the regurgitation of food and its re-chewing or re-swallowing.)\n##\n(\"entity\"<|>BACLOFEN<|>ORGANIZATION<|>Baclofen is a medication that has shown utility in improving regurgitation associated with rumination syndrome by increasing the pressure of the lower esophageal sphincter.)\n##\n(\"entity\"<|>DM<|>ORGANIZATION<|>DM refers to diabetes mellitus, a condition that complicates the management of patients with rumination syndrome, particularly in nutritional approaches.)\n##\n(\"entity\"<|>NUTRITIONAL MANAGEMENT<|>EVENT<|>Nutritional management is crucial for patients with rumination syndrome to prevent malnutrition and ensure adequate caloric intake.)\n##\n(\"entity\"<|>HIGH RESOLUTION MANOMETRY<|>EVENT<|>High resolution manometry (HRM) is a diagnostic test used to objectively assess esophageal function in patients suspected of having rumination syndrome.)\n##\n(\"entity\"<|>ELECTROMYOGRAPHY<|>EVENT<|>Electromyography is a diagnostic tool that can be useful in assessing abdominal wall muscle activity in patients with rumination syndrome.)\n##\n(\"entity\"<|>NUTRITIONAL FORMULAS<|>EVENT<|>Specific nutritional formulas for diabetes are recommended for patients with diabetes mellitus and rumination syndrome to facilitate better metabolic control.)\n##\n(\"relationship\"<|>RUMINATION SYNDROME<|>BACLOFEN<|>Baclofen is used to treat symptoms of rumination syndrome by increasing lower esophageal sphincter pressure<|>8)\n##\n(\"relationship\"<|>RUMINATION SYNDROME<|>DM<|>The presence of diabetes mellitus complicates the management of rumination syndrome, particularly in nutritional aspects<|>6)\n##\n(\"relationship\"<|>RUMINATION SYNDROME<|>NUTRITIONAL MANAGEMENT<|>Nutritional management is essential for preventing malnutrition in patients with rumination syndrome<|>9)\n##\n(\"relationship\"<|>RUMINATION SYNDROME<|>HIGH RESOLUTION MANOMETRY<|>High resolution manometry is a diagnostic test used to evaluate esophageal function in patients with rumination syndrome<|>7)\n##\n(\"relationship\"<|>RUMINATION SYNDROME<|>ELECTROMYOGRAPHY<|>Electromyography can help assess muscle activity related to rumination syndrome<|>5)\n##\n(\"relationship\"<|>DM<|>NUTRITIONAL FORMULAS<|>Specific nutritional formulas for diabetes are recommended for patients with diabetes and rumination syndrome to improve metabolic control<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ico y convencer al paciente del padecimiento de dicho trastorno, dado que algunos pacientes son reacios a aceptarlo⁴. Además, esa aceptación es fundamental para aumentar las posibilidades de éxito del tratamiento que es principalmente postural⁹.\n\nLa prueba complementaria más objetiva es la manometría esofágica de alta resolución (HRM) postprandial que puede combinarse con impedancia (HRIM)⁴ aunque escasos centros disponen de ella. También resultan de utilidad la electromiografía de la pared abdominal y la manometría gastroduodenal³.\n\nEl tratamiento más efectivo es la respiración diafragmática, que por un lado reduce la actividad de la musculatura abdominal anterior y en consecuencia disminuye también la presión intraabdominal e intragástrica, y por otro lado, aumenta la presión de la unión esofagogástrica³ contrarrestando de esa forma el mecanismo por el que se produce la regurgitación de los alimentos.\n\nEl baclofeno también ha demostrado utilidad en mejorar la regurgitación, asociándose tanto a su efecto en aumentar la presión basal del esfínter esofágico inferior como a sus efectos a nivel central¹⁰,¹¹.\n\nSe conoce poco acerca de la evolución a largo plazo del trastorno. En niños suele remitir espontáneamente, pero en adultos puede persistir durante meses, y el cumplimiento continuado del tratamiento durante varias semanas es fundamental para reducir la frecuencia de los episodios de regurgitación o incluso su resolución¹².\n\nDe momento no hay bibliografía donde se detalle cómo debe ser el manejo nutricional en esta patología. Un estudio menciona que se produce una pérdida de peso en un 42% de estos pacientes y que en ocasiones es necesario el empleo de nutrición\n---\nenteral o parenteral[^13] pero no aporta más detalles acerca de la vía y forma de abordaje nutricional.\n\nEn personas con DM y nutrición enteral domiciliaria, se recomienda la utiliza-ción de fórmulas específicas de diabetes frente a las estándar, dado que facilitan un mejor control metabólico[^14].\n\n## Conclusiones\n\nEl síndrome de rumiación es un trastorno poco conocido y probablemente infradiagnosticado. Su abordaje nutricional precoz resulta fundamental para prevenir la desnutrición asociada a un aporte calórico insuficiente. En personas con DM que además presentan esta patología, el control glucémico óptimo se convierte en un reto aún mayor.\n\n[^13]: Referencia 13 no proporcionada en la imagen.\n[^14]: Referencia 14 no proporcionada en la imagen.\n---\n# Bibliografía\n\n1. Cederholm T, Jensen GL, Correia MITD, González MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1-9.\n\n2. Fernández AP, Vitcopp GM. Yeyunostomías. Cirugía Digestiva. 2009; 243(2):1-7.\n\n3. Halland M, Pandolfino J, Barba E. Diagnosis and Treatment of Rumination Syndrome. Clin Gastroenterol Hepatol. 2018;16(10):1549-55.\n\n4. Kessing BF, Bredenoord AJ, Smout AJPM. Objective Manometric Criteria for the Rumination Syndrome: Am J Gastroenterol. 2014;109(1):52-9.\n\n5. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada J-R, et al. Functional Gastroduodenal Disorders. Gastroenterology. 2006;130(5):1466-79.\n\n6. Stanghellini V, Chan FKL, Hasler WL, Malagelada JR, Suzuki H, Tack J, et al. Gastroduodenal Disorders. Gastroenterology. 2016;150(6):1380-92.\n\n7. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol. 2002;97(9):2290-9.\n\n8. López-Colombo A, Morgan D, Bravo-González D, Montiel-Jarquín A, Méndez-Martínez S, Schmulson M. The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study. Gastroenterol Res Pract. 2012;2012:1-8.\n\n9. Absah I, Rishi A, Talley NJ, Katzka D, Halland M. Rumination syndrome: pathophysiology, diagnosis, and treatment. Neurogastroenterol Motil. 2017;29(4):e12954.\n\n10. Blondeau K, Boecxstaens V, Rommel N, Farré R, Depeyper S, Holvoet L, et al. Baclofen Improves Symptoms and Reduces Postprandial Flow Events in Patients With Rumination and Supragastric Belching. Clin Gastroenterol Hepatol. 201\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}